Literature DB >> 10468018

Solid-state characteristics of amorphous sodium indomethacin relative to its free acid.

P Tong1, G Zografi.   

Abstract

PURPOSE: Having previously studied the amorphous properties of indomethacin (IN) as a model compound for drugs rendered amorphous during processing, we report on the formation and characterization of its sodium salt in the amorphous state and a comparison between the two systems.
METHODS: Sodium indomethacin (SI) was subjected to lyophilization from aqueous solution, rapid precipitation from methanol solution, and dehydration followed by grinding to produce, in each case, a completely amorphous form. The amorphous form of SI was analyzed using DSC, XRD, thermomicroscopy and FTIR. The method of scanning rate dependence of the glass transition temperature, Tg, was used to estimate the fragility of the SI system. Enthalpy relaxation experiments were carried out to probe the molecular mobility of the SI system below Tg.
RESULTS: The amorphous form of SI formed by different methods had a Tg equal to 121 degrees C at a scanning rate of 20 degrees C/min. This compares with a Tg for indomethacin of 45 degrees C. Estimation of fragility by the scanning rate dependence of Tg indicates no significant differences in fragility between ionized and unionized forms. Enthalpy relaxation measurements reveal very similar relaxation patterns between the two systems at the same degree of supercooling relative to their respective Tg values.
CONCLUSIONS: The amorphous form of SI made by various methods has a Tg that is about 75 degrees C greater than that of IN, most likely because of the greater density and hence lower free volume of SI. Yet, the change of molecular mobility as a function of temperature relative to Tg is not very different between the ionized and unionized systems.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10468018     DOI: 10.1023/a:1018985110956

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  14 in total

1.  Isolation and solid-state characteristics of a new crystal form of indomethacin.

Authors:  S Y Lin
Journal:  J Pharm Sci       Date:  1992-06       Impact factor: 3.534

2.  Dissolution rates of high energy sulfathiazole--povidone coprecipitates II: characterization of form of drug controlling its dissolution rate via solubility studies.

Authors:  A P Simonelli; S C Mehta; W I Higuchi
Journal:  J Pharm Sci       Date:  1976-03       Impact factor: 3.534

3.  The molecular mobility of supercooled amorphous indomethacin as a function of temperature and relative humidity.

Authors:  V Andronis; G Zografi
Journal:  Pharm Res       Date:  1998-06       Impact factor: 4.200

4.  Molecular mobility of supercooled amorphous indomethacin, determined by dynamic mechanical analysis.

Authors:  V Andronis; G Zografi
Journal:  Pharm Res       Date:  1997-04       Impact factor: 4.200

5.  Some physicochemical properties of glassy indomethacin.

Authors:  E Fukuoka; M Makita; S Yamamura
Journal:  Chem Pharm Bull (Tokyo)       Date:  1986-10       Impact factor: 1.645

6.  Differential thermal, solubility, and aging studies on various sources of digoxin and digitoxin powder: biopharmaceutical implications.

Authors:  W L Chiou; L E Kyle
Journal:  J Pharm Sci       Date:  1979-10       Impact factor: 3.534

7.  Cefoxitin sodium: solution and solid-state chemical stability studies.

Authors:  E R Oberholtzer; G S Brenner
Journal:  J Pharm Sci       Date:  1979-07       Impact factor: 3.534

8.  Crystal and molecular structure of an antiinflammatory agent, indomethacin, 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid.

Authors:  T J Kistenmacher; R E Marsh
Journal:  J Am Chem Soc       Date:  1972-02-23       Impact factor: 15.419

9.  1-acyl-indoles. II. A new syntheses of 1-(p-chlorobenzoyl)-5-methyoxy-3-indolyacetic acid and its polymorphism.

Authors:  H Yamamoto
Journal:  Chem Pharm Bull (Tokyo)       Date:  1968-01       Impact factor: 1.645

10.  Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures.

Authors:  B C Hancock; S L Shamblin; G Zografi
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

View more
  16 in total

1.  Influence of alkali metal counterions on the glass transition temperature of amorphous indomethacin salts.

Authors:  Ping Tong; Lynne S Taylor; George Zografi
Journal:  Pharm Res       Date:  2002-05       Impact factor: 4.200

2.  Microcalorimetric measurement of the interactions between water vapor and amorphous pharmaceutical solids.

Authors:  David Lechuga-Ballesteros; Aziz Bakri; Danforth P Miller
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

3.  Preparation and characterization of co-grinded mixtures of aceclofenac and neusilin US2 for dissolution enhancement of aceclofenac.

Authors:  Ambarish H Vadher; Jolly R Parikh; Rajesh H Parikh; Ajay B Solanki
Journal:  AAPS PharmSciTech       Date:  2009-05-15       Impact factor: 3.246

4.  Effect of Formulation and Process Parameters on the Disproportionation of Indomethacin Sodium in Buffered Lyophilized Formulations.

Authors:  Sampada Koranne; Seema Thakral; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2018-01-05       Impact factor: 4.200

5.  Salt formation during freeze-drying--an approach to enhance indomethacin dissolution.

Authors:  Seema Thakral; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2015-06-11       Impact factor: 4.200

6.  Thermophysical properties of pharmaceutically compatible buffers at sub-zero temperatures: implications for freeze-drying.

Authors:  Evgenyi Y Shalaev; Tiffany D Johnson-Elton; Liuquan Chang; Michael J Pikal
Journal:  Pharm Res       Date:  2002-02       Impact factor: 4.200

7.  Analysis of relationships between solid-state properties, counterion, and developability of pharmaceutical salts.

Authors:  Peter Guerrieri; Alfred C F Rumondor; Tonglei Li; Lynne S Taylor
Journal:  AAPS PharmSciTech       Date:  2010-08-03       Impact factor: 3.246

8.  Effects of water vapor absorption on the physical and chemical stability of amorphous sodium indomethacin.

Authors:  Ping Tong; George Zografi
Journal:  AAPS PharmSciTech       Date:  2004-03-12       Impact factor: 3.246

9.  Amorphization of Indomethacin by Co-Grinding with Neusilin US2: amorphization kinetics, physical stability and mechanism.

Authors:  Deepak Bahl; Robin H Bogner
Journal:  Pharm Res       Date:  2006-08-23       Impact factor: 4.200

10.  Amorphization alone does not account for the enhancement of solubility of drug co-ground with silicate: the case of indomethacin.

Authors:  Deepak Bahl; Robin H Bogner
Journal:  AAPS PharmSciTech       Date:  2008-01-19       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.